Myeloid-derived suppressor cells in sepsis.

Area of Science:

• Immunology
• Critical Care Medicine
• Pathophysiology

Background:

• Sepsis is a life-threatening systemic response to infection, leading to organ dysfunction and high mortality rates globally.
• Sepsis-associated immunosuppression is a key factor in patient mortality, highlighting the need for novel immune-modulating therapies.
• Myeloid-derived suppressor cells (MDSCs) are elevated during sepsis and possess immunosuppressive properties.

Purpose of the Study:

• To discuss the multifaceted role of MDSCs in immune regulation during sepsis.
• To explore the potential of targeting MDSCs for therapeutic benefit in sepsis patients.

Main Methods:

• Review of existing clinical research and literature on sepsis and MDSC function.
• Analysis of the dual role of MDSCs in innate and adaptive immunity during sepsis.

Main Results:

• MDSCs exhibit heterogeneous functions, with some evidence suggesting beneficial roles in innate immunity and antimicrobial activity.
• Conversely, MDSC expansion can lead to adaptive immune suppression, increasing susceptibility to secondary infections.
• The precise role of MDSCs in sepsis pathogenesis remains uncertain, necessitating further investigation.

Conclusions:

• MDSCs represent a complex regulatory component of the immune response in sepsis.
• Targeting MDSCs presents a potential therapeutic strategy for sepsis, though their dual role requires careful consideration.